Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
430 daily bars · split adjusted
Current price $10.80
Latest analyst grade actions
Daily · Wilder smoothing
Classic floor pivots from 2023-10-13
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 51.09 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 33.35 | Oscillator | Neutral |
| Williams %R (14) | -66.61 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.01 (Hist -0.01) | Oscillator | Sell |
| Average Directional Index (14) | 54.40 (+DI 56.3 / -DI 26.7) | Trend |
| EMA 20 | 10.80 | MA | Sell |
| SMA 20 | 10.81 | MA | Sell |
| EMA 50 | 10.77 | MA | Buy |
| SMA 50 | 10.77 | MA | Buy |
| SMA 200 | 10.54 | MA | Buy |
Stock news · updated daily
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jun 30, 2023 | — | 0.05 | — | — |
| Mar 31, 2023 | — | 0.17 | — | — |
| Dec 31, 2022 | — | 0.01 | — | — |
SEC EDGAR filings · last 12 months
Proxy statement (DEF 14A) disclosures
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Jun 5, 23 | Bioplus Sponsor Llc | 10 percent owner | C-Conversion | 5,749,999 @ $0.0001 | $575 |
| Jun 5, 23 | Bioplus Sponsor Llc | 10 percent owner | C-Conversion | 5,749,999 | — |
| Dec 7, 21 | Bioplus Sponsor Llc | 10 percent owner | J-Other | 380,000 @ $10.00 | $3.80M |
| Dec 7, 21 | Bioplus Sponsor Llc | 10 percent owner | J-Other | 0 @ $10.00 | $0 |
| Dec 2, 21 | Bioplus Sponsor Llc | 10 percent owner | I | 5,175,000 | — |
| Dec 2, 21 | Giovannetti Glen | director: | 0 | — | |
| Dec 2, 21 | Sherwin Stephen A | director: | 0 | — | |
| Dec 2, 21 | Lange Louis G | director: | 0 | — |
TTM vs. 5-year historical average (annual ratios)
| Metric | BIOS | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 54.0x | -90.1x · sector 20.4x | Elevated |
| Forward P/E | — | — | n/a |
| Price / Book | 1.3x | -90.0x | Discount |
| Price / Sales | — | 0.8x | Discount |
| EV / EBITDA | 182691.6x | 52407.4x | Elevated |
| Return on equity | 2.3% | — | Weak |
| Gross margin | 0.0% | 19.1% | Below hist. |
| Debt / Equity | 0.02 | -35.34 | Conservative |
| Piotroski / Altman Z | 2/9 | Z 7.26 | Safe zone |
Discounted cash flow model